logo
  Join        Login             Stock Quote

Sanofi (SNY) Plans To Raise Stake In Regeneron (REGN), Shares Up

 February 11, 2013 02:38 PM
 


(By Balachander) Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) said its partner Sanofi SA (NYSE: SNY) plans to raise its stake in the drug maker by acquiring shares in open market.

REGN stock, which has risen 24 percent in the last 3 months, gained 2.79 percent to trade at $170.50 on Monday. SNY shares jumped 3.42 percent to trade at $48.11.

France-based Sanofi, which currently owns roughly 16 million shares or 17 percent of Regeneron, plans to own in excess of $500 million in voting securities.

[Related -Regeneron Pharmaceuticals Inc (REGN): Well Positioned To Rival Amgen In Multi-Billion Dollar Cholesterol Drug Market]

Under a December 2007 investor agreement, Sanofi is bound by certain "standstill" provisions including an agreement not to acquire more than 30 percent of Regeneron's class A stock and common stock. 

These standstill provisions are effective until the fifth anniversary of the expiration or earlier termination of a license and collaboration agreement between the companies, the Tarrytown, New York-based Regeneron said.

Sanofi and Regeneron have both developed cancer drug Zaltrap, which has been approved by the U.S. Food and Drug Administration (FDA) and European regulators as a treatment for colorectal cancer. The companies have also agreed to colloborate on other drugs.

REGN shares have been trading in the 52-week range of $94.22 to $188.95.

iOnTheMarket Premium
Advertisement

Advertisement


Post Comment -- Login is required to post message
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
 

rss feed

Latest Stories

article imageHow Apple Could Send This Emerging Market Into Overdrive

Don't get distracted by the alphabet soup of emerging market investing -- there are other areas to get read on...

article imageJobless Claims Fell Last Week, Underlining Bullish Trend

New filings for unemployment benefits fell 2,000 to a seasonally adjusted 291,000 for the week through read on...

article image26.25% Annual Return With Lobbying Stocks?

I found an interesting portfolio investing idea: Invest into stocks that spend a huge amount of money to read on...

article imageGlobal Economic Picture Worsens Further.

The Markit PMI Indexes for November are out for a number of countries this morning, and almost all were read on...

Advertisement
Popular Articles

Advertisement
Daily Sector Scan
Partner Center



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.